Association of Serum YKL-40 and Oxidative Stress Biomarkers with Glioma Grade: A Case-Control Study
This case-control study demonstrates that while elevated oxidative stress markers distinguish glioma patients from healthy controls, serum YKL-40 levels uniquely correlate with tumor grade, suggesting its potential as a biomarker for differentiating between low- and high-grade gliomas.